In non-small-cell lung cancer (NSCLC), reduced HOXA5 expression correlates with larger tumor size, lymph node metastasis, and worse outcomes, partially through p21-mediated growth inhibition [18]. Here, HOXA5 is linked to non-small cell lung carcinoma.